Elevated aqueous TNF-α levels are associated with more severe functional and anatomic findings in eyes with diabetic macular oedema.
Journal: Clinical & experimental ophthalmology
Year: March 08, 2024
Ophthalmologist
4.5
No OPD information available
Age-Related Macular Degeneration (ARMD)
Diabetic Macular Edema (DME)
Late-Onset Retinal Degeneration
Cataract Removal
Diabetic Retinopathy
Cataract
Iridectomy
Pterygium
Retinal Artery Occlusion
Retinal Vein Occlusion
Sanjeewa S. Wickremasinghe is a doctor who helps people with eye problems like Age-Related Macular Degeneration, Diabetic Macular Edema, and other eye conditions. He also does surgeries like cataract removal and iridectomy to help people see better.
Sanjeewa S. Wickremasinghe is good at talking to patients and explaining things in a way that is easy to understand. Patients trust him because he listens to their concerns and treats them with kindness and respect.
To make sure he knows the latest information, Sanjeewa S. Wickremasinghe reads a lot of medical research papers and attends conferences. This helps him stay up-to-date on new treatments and technologies.
Sanjeewa S. Wickremasinghe works well with other doctors and healthcare professionals. He shares his knowledge and learns from his colleagues to provide the best care for his patients.
One of his studies found that high levels of a substance called TNF-α in the eyes of patients with Diabetic Macular Edema are linked to more severe eye problems. This discovery can help doctors better understand and treat this condition.
Sanjeewa S. Wickremasinghe also led a clinical trial to test a new treatment for Diabetic Macular Edema. The study showed that the treatment was safe for patients, which is good news for people with this eye condition.
In summary, Sanjeewa S. Wickremasinghe is a caring and knowledgeable doctor who works hard to help people with eye problems. His research and clinical trials contribute to improving treatments for eye conditions, benefiting many patients.
Journal: Clinical & experimental ophthalmology
Year: March 08, 2024
Enrollment Status: Completed
Published: January 10, 2023
Intervention Type: Drug
Study Drug: EXN407
Study Phase: Phase 1/Phase 2
Dr. Wickremasinghe is a fantastic Ophthalmologist! He explained everything clearly and made me feel at ease during my eye exam. Highly recommend!
I had a great experience with Dr. Wickremasinghe. He was very professional and caring. My eye surgery went smoothly, and I am grateful for his expertise.
Dr. Wickremasinghe is a skilled Ophthalmologist. He helped me with my eye condition and provided excellent care. I feel confident in his abilities.
I am so pleased with the care I received from Dr. Wickremasinghe. He is knowledgeable and compassionate. I trust him completely with my eye health.
Dr. Wickremasinghe is a top-notch Ophthalmologist. He took the time to listen to my concerns and provided thorough explanations. I am very satisfied with his services.